Tag Archives: Doses

CDC and FDA Expedite the Availability of Additional Doses of New RSV Immunization for Infants

Today, CDC announced the release of more than 77,000 additional doses of Beyfortus(TM) (nirsevimab-alip (100 mg), a long-acting monoclonal antibody designed to protect infants against severe respiratory syncytial virus (RSV) disease. 

New COVID-19 Vaccine Effectiveness Data Showcase Protection Gained by 3rd and 4th Doses

A third and fourth COVID-19 vaccine dose offered substantial protection among adults with healthy immune systems who were eligible to receive them during Omicron variant evolution in early 2022.